hydroxyurea has been researched along with Mast Cell Activation Disease in 3 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Patients with clonal mast cell activation syndromes (MCAS) including cutaneous and systemic mastocytosis (SM) may present with symptoms of mast cell activation, but in addition can have organ damage from the local effects of tissue infiltration by clonal mast cells." | 2.61 | Mast Cell Activation Syndrome and Mastocytosis: Initial Treatment Options and Long-Term Management. ( Butterfield, J; Castells, M, 2019) |
| "Determine efficacy and adverse events (AEs) of hydroxyurea (HU) in mast cell activation syndrome (MCAS) patients who were refractory to standard medical therapy." | 1.72 | Efficacy and toxicity of hydroxyurea in mast cell activation syndrome patients refractory to standard medical therapy: retrospective case series. ( Brook, JB; Molderings, GJ; Weinstock, LB, 2022) |
| "Some sickle cell anemia (SCA) patients suffer significantly worse phenotypes than others." | 1.40 | Mast cell activation syndrome as a significant comorbidity in sickle cell disease. ( Afrin, LB, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Weinstock, LB | 1 |
| Brook, JB | 1 |
| Molderings, GJ | 1 |
| Castells, M | 1 |
| Butterfield, J | 1 |
| Afrin, LB | 1 |
1 review available for hydroxyurea and Mast Cell Activation Disease
| Article | Year |
|---|---|
Mast Cell Activation Syndrome and Mastocytosis: Initial Treatment Options and Long-Term Management.
Topics: Anti-Allergic Agents; Anti-Asthmatic Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cromo | 2019 |
2 other studies available for hydroxyurea and Mast Cell Activation Disease
| Article | Year |
|---|---|
Efficacy and toxicity of hydroxyurea in mast cell activation syndrome patients refractory to standard medical therapy: retrospective case series.
Topics: Abdominal Pain; Adult; Diarrhea; Female; Humans; Hydroxyurea; Mast Cell Activation Syndrome; Mast Ce | 2022 |
Mast cell activation syndrome as a significant comorbidity in sickle cell disease.
Topics: Adult; Anemia, Sickle Cell; Antisickling Agents; Caseins; Chromogranin A; Cohort Studies; Female; He | 2014 |